Alnylam Pharmaceuticals Price Target Raised to $275.00/Share From $242.00 by Raymond James

阿里拉姆製藥的價格目標由Raymond James從242.00美元/股上調至275.00美元/股。

道瓊斯 · 08/02 13:56 · 評級/大行評級

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.